Back to Network
4
Shared Docs
4
Same-Page
4 / 4
Mentions
Document Mentions (4 shared documents)
2 mentions1 same-page
Page ?Same page
m pests and invasive species. Lead by Kevin Esvelt. This will probably be in the news on July 17. Business model similar to the relationship between Amyris and the Gates Foundation for manufacturing anti-malaria drugs. 6) Making human genetic disease models in organoids and aging reversal using CRISPR
. Lead by Rich Terry. 8) Genome engineering of humans for space. Seed money for patent fees, some lab tests and education efforts via pgEd. Lead by Ting Wu. 9) Making cold-resistant elephants via CRISPR, focusing on blood, subcutaneous fat and wool/hair (based on what is know about cold-resistant anima
2 mentions1 same-page
Page ?Same page
m pests and invasive species. Lead by Kevin Esvelt. This will probably be in the news on July 17. Business model similar to the relationship between Amyris and the Gates Foundation for manufacturing anti-malaria drugs. 6) Making human genetic disease models in organoids and aging reversal using CRISPR
. Lead by Rich Terry. 8) Genome engineering of humans for space. Seed money for patent fees, some lab tests and education efforts via pgEd. Lead by Ting Wu. 9) Making cold-resistant elephants via CRISPR, focusing on blood, subcutaneous fat and wool/hair (based on what is know about cold-resistant anima
2 mentions1 same-page
Page ?Same page
m pests and invasive species. Lead by Kevin Esvelt. This will probably be in the news on July 17. Business model similar to the relationship between Amyris and the Gates Foundation for manufacturing anti-malaria drugs. 6) Making human genetic disease models in organoids and aging reversal using CRISPR
. Lead by Rich Terry. 8) Genome engineering of humans for space. Seed money for patent fees, some lab tests and education efforts via pgEd. Lead by Ting Wu. 9) Making cold-resistant elephants via CRISPR, focusing on blood, subcutaneous fat and wool/hair (based on what is know about cold-resistant anima
Sponsored
2 mentions1 same-page
Page ?Same page
m pests and invasive species. Lead by Kevin Esvelt. This will probably be in the news on July 17. Business model similar to the relationship between Amyris and the Gates Foundation for manufacturing anti-malaria drugs. 6) Making human genetic disease models in organoids and aging reversal using CRISPR
. Lead by Rich Terry. 8) Genome engineering of humans for space. Seed money for patent fees, some lab tests and education efforts via pgEd. Lead by Ting Wu. 9) Making cold-resistant elephants via CRISPR, focusing on blood, subcutaneous fat and wool/hair (based on what is know about cold-resistant anima
Sponsored
Mutual Connections (18)
Entities connected to both Amyris and Ting Wu
Jeffrey Epstein
PERSON7 w/ Amyris·6 w/ Ting
Marc Rich
PERSON7 w/ Amyris·4 w/ Ting
JQ
Justin Quinn
PERSON4 w/ Amyris·4 w/ Ting
Space Genetics
ORGANIZATION4 w/ Amyris·4 w/ Ting
Justin Trudeau
PERSON4 w/ Amyris·4 w/ Ting
JC
James Clement
PERSON4 w/ Amyris·4 w/ Ting
Robert Gates
PERSON4 w/ Amyris·4 w/ Ting
KE
Kevin Esvelt
PERSON4 w/ Amyris·4 w/ Ting
PM
Prashant Mali
PERSON4 w/ Amyris·4 w/ Ting
DM
Dan Mandell
PERSON4 w/ Amyris·4 w/ Ting
RT
Rich Terry
PERSON4 w/ Amyris·4 w/ Ting
BD
Bobby Dhadwar
PERSON4 w/ Amyris·4 w/ Ting
MM
Margo Monroe
PERSON4 w/ Amyris·4 w/ Ting
the American Bison
ORGANIZATION3 w/ Amyris·3 w/ Ting
Eric Trump
PERSON3 w/ Amyris·3 w/ Ting
ES
Eswar
PERSON3 w/ Amyris·3 w/ Ting
LY
Luhan Yang
PERSON3 w/ Amyris·3 w/ Ting
HE
Helicos
PERSON2 w/ Amyris·2 w/ Ting